Overview

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Status:
Suspended

Trial end date:
2023-01-14

Target enrollment:

Participant gender:

Summary

This early phase I trial studies how well hyperpolarized carbon C 13 pyruvate magnetic resonance imaging works in detecting lactate and bicarbonate in participants with central nervous system tumors. Hyperpolarized carbon C 13 pyruvate magnetic resonance imaging may be used to measure the metabolic state of malignant brain tumors.

Phase:

Phase 1

Details

Lead Sponsor:

Daniel M. Spielman

Collaborator:

National Institutes of Health (NIH)